Buttini; Manuel J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buttini; Manuel J..The latest application filed is for "prevention and treatment of synucleinopathic and amyloidogenic disease".

Company Profile

2.7.19

Buttini; Manuel J. - Emeryville CA
BUTTINI; MANUEL J. - BELVAUX LU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20210032318 - Schenk; Dale B. ; et al.	2021-02-04
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20190300598 - SCHENK; DALE B. ; et al.	2019-10-03
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20170349651 - Schenk; Dale B. ; et al.	2017-12-07
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20160184416 - Schenk; Dale B. ; et al.	2016-06-30
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20160060331 - Schenk; Dale B. ; et al.	2016-03-03
Use of tau to monitor immunotherapy Grant 9,272,030 - Black , et al. March 1, 2	2016-03-01
Treatment and delay of outset of synucleinopathic and amyloidogenic disease Grant 9,034,337 - Schenk , et al. May 19, 2	2015-05-19
Use Of Tau To Monitor Immunotherapy App 20150118223 - Black; Ronald ; et al.	2015-04-30
Use Of Tau To Monitor Immunotherapy App 20130209453 - Black; Ronald ; et al.	2013-08-15
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20120201842 - Schenk; Dale B. ; et al.	2012-08-09
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20120142902 - Schenk; Dale B. ; et al.	2012-06-07
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,147,833 - Schenk , et al. April 3, 2	2012-04-03
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,092,801 - Schenk , et al. January 10, 2	2012-01-10
Treatment and delay of onset of synucleinopathic and amyloidogenic disease Grant 7,919,088 - Schenk , et al. April 5, 2	2011-04-05
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100278814 - Schenk; Dale B. ; et al.	2010-11-04
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20100086545 - Schenk; Dale B. ; et al.	2010-04-08
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100031377 - Schenk; Dale B ; et al.	2010-02-04
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20090208487 - Schenk; Dale B. ; et al.	2009-08-20
Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease App 20080175838 - Schenk; Dale B. ; et al.	2008-07-24
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20080014194 - Schenk; Dale B. ; et al.	2008-01-17
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20060058233 - Schenk; Dale B. ; et al.	2006-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.